^{Research & Development

The ablation device AMTC300B of Admetech has received medical device

certification in Ukraine. Of 60 patients with recurrent

pancreatic cancer,

57 cases of PR and 3 cases of SD have been clinically reported.

In a clinical study in Japan, it succeeded in erasing the tumor of an 87-year-old

patient with cancer at the junction of the stomach and esophagus who was inoperable.

Pre-surgery and post-surgery pictures.

We are looking for a Hong Kong partner for AMTC300B clinical research.}

^{CELL Co., Ltd. conducts stem cell culture contract business and cancer

immune cell culture contract business at a specific cell processing factory

licensed by the Japanese government.

We arrange technology transfer from CELL to Hong Kong.}